deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT00908622

Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction (PERCUTANEO)

Phase II, Blind, Controlled, Randomised Study of the Efficacy of Percutaneous Implantation of Autologous Myoblasts in Patients With Old Infarction

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Old Myocardial Infarction
Interventions Cardiac revascularization Percutaneous autologous myoblast implantation
Updated 5 times since 2017 Last updated: Sep 10, 2015 Started: Mar 31, 2007 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of enrollment

Other terminated trials from Clinica Universidad de Navarra, Universidad de Navarra

See all terminations from Clinica Universidad de Navarra, Universidad de Navarra

Other Old Myocardial Infarction trials with similar outcome

Browse all Old Myocardial Infarction trials

This PHASE2 trial investigates Old Myocardial Infarction and is currently terminated or withdrawn. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinica Universidad de Navarra, Universidad de Navarra
  • Finabiotech
Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations